AP NEWS
Press release content from BusinessWire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from BusinessWire
Press release content from BusinessWire. The AP news staff was not involved in its creation.

Global Continuous Subcutaneous Insulin Therapy Devices (CSITD) Market: 2019-2023 - ResearchAndMarkets.com

January 9, 2019

DUBLIN--(BUSINESS WIRE)--Jan 9, 2019--The “Global Continuous Subcutaneous Insulin Therapy Devices (CSITD) Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.

T he continuous subcutaneous insulin therapy devices market will register a CAGR of more than 9% by 2023.

The rising partnerships to gain prominence in the market

Vendors are entering into strategic alliances and partnerships for integration of available and emerging technologies into their products. Such partnerships will help the market to grow.

Rise in awareness about diabetes

The rise in prevalence of diabetes has resulted in increasing awareness efforts by various organizations globally. Programs such as the Diabetes Activities Under State Public Health Actions increase the participation of people.

Rise in product recalls

The growth of the market is hindered by product recalls. Product recalls affect the sales of a company negatively, which results in a decline in it market share. Also, they affect the brand image of vendors, thereby reducing profit margins.

Key Players

Cellnovo F. Hoffmann-La Roche Insulet Medtronic Tandem Diabetes Care

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

Market ecosystem Market characteristics Market segmentation analysis

PART 04: MARKET SIZING

Market definition Market sizing 2018 Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

PART 06: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product Comparison by product Tethered - Market size and forecast 2018-2023 Patch - Market size and forecast 2018-2023 Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation Geographic comparison Americas - Market size and forecast 2018-2023 EMEA - Market size and forecast 2018-2023 APAC - Market size and forecast 2018-2023 Key leading countries Market opportunity

PART 09: DRIVERS AND CHALLENGES

PART 10: MARKET TRENDS

Technological advances Increase in grants for product development Rise in strategic partnerships

PART 11: VENDOR LANDSCAPE

Overview Landscape disruption Competitive scenario

PART 12: VENDOR ANALYSIS

Vendors covered Vendor classification Market positioning of vendors Cellnovo F. Hoffmann-La Roche Insulet Medtronic Tandem Diabetes Care

For more information about this report visit https://www.researchandmarkets.com/research/jb3wgc/global_continuous?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190109005375/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Endocrine and Metabolic Disorders Drugs,Diabetes Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES DIABETES

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/09/2019 06:41 AM/DISC: 01/09/2019 06:41 AM

http://www.businesswire.com/news/home/20190109005375/en